Literature DB >> 3189305

Permanent neurological complications in patients with thrombotic thrombocytopenic purpura.

D Ben-Yehuda1, M Rose, Y Michaeli, A Eldor.   

Abstract

According to previous clinical studies, the neurological manifestations observed in patients with thrombotic thrombocytopenic purpura (TTP) are considered to be transient. The introduction of plasma therapy in 1977 as major treatment modality for TTP has changed the prognosis of the disease. In a clinical survey of 38 patients with TTP who received plasma therapy, we have observed five patients who developed permanent neurological deficits despite their prompt recovery from TTP. In this study, we describe the new complication of TTP and summarize the neurological manifestations observed in these patients during their first episode of TTP and during the relapses, which occurred in 12 of them.

Entities:  

Mesh:

Year:  1988        PMID: 3189305     DOI: 10.1002/ajh.2830290204

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  2 in total

1.  Brain MRI and SPET in thrombotic thrombocytopenic purpura.

Authors:  L Fiorani; N Vianelli; L Gugliotta; L Vignatelli; C Corbelli; R D'Alessandro
Journal:  Ital J Neurol Sci       Date:  1995-04

Review 2.  The thrombocytopenic purpuras. Recognition and management.

Authors:  S Gillis
Journal:  Drugs       Date:  1996-06       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.